ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,814.00
      -0.16%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.625
      -0.85%
      Bitcoin
      62,547.12
      -3.55%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Celgene Corporation (CELG)

      7. Celgene Corporation (CELG) News

      CELG

      Celgene (CELG)

      Celgene Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CELG
      DateTimeSourceHeadlineSymbolCompany
      03/05/20194:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      03/05/20194:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      03/05/20194:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      03/05/20194:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      03/05/20194:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      03/05/20194:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      03/05/20198:19AMDow Jones NewsCelgene Gets FDA Priority Review for Fedratinib in MyelofibrosisNASDAQ:CELGCelgene Corporation
      03/05/20197:30AMBusiness WireU.S. FDA Grants Priority Review for Fedratinib New Drug Application in MyelofibrosisNASDAQ:CELGCelgene Corporation
      03/05/20196:10AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
      03/04/20194:38PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
      03/01/20194:05PMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:CELGCelgene Corporation
      03/01/20193:02AMDow Jones NewsActivist Investor Pans Deal At Bristol Activist Investor Hits Deal At Bristol -- WSJNASDAQ:CELGCelgene Corporation
      02/28/20194:33PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
      02/28/20191:21PMDow Jones NewsStarboard Details Opposition to Bristol-Myers Deal for Celgene -- 2nd UpdateNASDAQ:CELGCelgene Corporation
      02/28/201911:33AMDow Jones NewsStarboard Details Opposition to Bristol-Myers Deal for Celgene -- UpdateNASDAQ:CELGCelgene Corporation
      02/28/201910:56AMDow Jones NewsCelgene Shares Fall as Big Bristol-Myers Holders Grow RestiveNASDAQ:CELGCelgene Corporation
      02/28/201910:45AMDow Jones NewsStarboard Details Opposition to Bristol-Myers Deal for CelgeneNASDAQ:CELGCelgene Corporation
      02/28/20196:12AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
      02/28/20193:02AMDow Jones NewsBig Bristol-Myers Investor Opposes Deal -- WSJNASDAQ:CELGCelgene Corporation
      02/27/20199:43PMDow Jones NewsBig Bristol-Myers Shareholder Opposes Celgene Deal--UpdateNASDAQ:CELGCelgene Corporation
      02/27/20197:12PMDow Jones NewsBig Bristol-Myers Shareholder Opposes Celgene DealNASDAQ:CELGCelgene Corporation
      02/26/20198:54AMDow Jones NewsCelgene to File Luspatercept BLA With FDA in AprilNASDAQ:CELGCelgene Corporation
      02/26/20198:44AMDow Jones NewsCelgene Gets FDA Priority Review of Revlimid/Rituximab Combo in LymphomaNASDAQ:CELGCelgene Corporation
      02/26/20197:30AMBusiness WireCelgene Corporation Announces Key Regulatory Updates for REVLIMID® in Lymphoma and Luspatercept in MDS and Beta-ThalassemiaNASDAQ:CELGCelgene Corporation
      02/26/20196:03AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:CELGCelgene Corporation
      02/25/20197:17AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
      02/22/20195:07PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
      02/22/20194:55PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
      02/22/20194:33PMEdgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:CELGCelgene Corporation
      02/20/20195:06PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
       Showing the most relevant articles for your search:NASDAQ:CELG